Flotation

Xilio Therapeutics tunes into $118m IPO
25th October 2021
Alessia Argentieri
Takeda, Merck & Co, Ipsen and Merck Group all scored exits as the immuno-oncology drug developer floated at the bottom of its IPO range.
Q4 reaches the front of IPO queue
25th October 2021
Robert Lavine
The market communicationns platform developer is going public today in an $81m initial public offering which will enable OpenText to exit.
Abbisko nabs $226m in IPO
20th October 2021
Liwen-Edison Fu
AstraZeneca, Eli Lilly and Sinopharm all achieved exits as the cancer therapy developer listed on the Hong Kong Stock Exchange at a reported valuation of nearly $1.1bn.
Pyxis progresses to stock market
11th October 2021
Thierry Heles
Bayer, Pfizer and Ipsen-backed cancer therapeutics developer Pyxis Oncology priced its shares at the top of its range.
Exscientia expands IPO to over $350m
6th October 2021
Robert Lavine
The cancer drug developer has closed an initial public offering which took place alongside a $160m SoftBank-led private placement.
Safie seals public listing
6th October 2021
Liwen-Edison Fu
Canon, Kansai Electric Power, Mitsui Fudosan, NEC, NTT Docomo, So-net and T-Gaia were among the investors that scored exits as the CCTV system provider went public.
Exscientia establishes Nasdaq listing
4th October 2021
Robert Lavine
SoftBank invested $125m through a $160m private placement as portfolio company and cancer drug developer Exscientia went public in an offering sized at nearly $305m.
Oxford Nanopore fetches $478m in IPO
1st October 2021
Thierry Heles
Tencent, Nikon, Amgen and Illumina all scored exits as the DNA sequencing provider's shares popped in the wake of its flotation.

Other News

Warby Parker wraps up direct listing
30th September 2021
Robert Lavine
The American Express-backed eyewear retailer's market capitalisation exceeded $6.1bn in the wake of its direct listing on the New York Stock Exchange.
Toast tops off $1bn initial public offering
27th September 2021
Robert Lavine
The GV-backed restaurant organisation platform developer has issued $130m in additional shares to close its IPO and has a market capitalisation above $28bn.
Broncus broadcasts $215m IPO news
27th September 2021
Liwen-Edison Fu
The Baidu Capital and Intuitive Surgical-backed lung disease-focused medical devices developer’s Hong Kong offering valued it at about $1.3bn.
Cue Health counts up $200m in IPO
27th September 2021
Fernando Moncada Rivera
The Johnson and Johnson, Dentsu and Koch Industries-backed diagnostics device developer priced its initial public offering in the middle of its range.
Remitly rakes in $523m in IPO
24th September 2021
Jordan Williams
Prosus, Visa, and Prudential Financial scored exits as Remitly went public, with Prudential divesting $32.5m of shares through the offering.
Freshworks' IPO tops $1bn
23rd September 2021
Jordan Williams
Alphabet-backed CRM software provider Freshworks floated above its range and now boasts a market cap of $13.5bn.

Editor's Picks

Abbisko nabs $226m in IPO
20th October 2021
Liwen-Edison Fu
AstraZeneca, Eli Lilly and Sinopharm all achieved exits as the cancer therapy developer listed on the Hong Kong Stock Exchange at a reported valuation of nearly $1.1bn.
Toast tops off $1bn initial public offering
27th September 2021
Robert Lavine
The GV-backed restaurant organisation platform developer has issued $130m in additional shares to close its IPO and has a market capitalisation above $28bn.
Remitly rakes in $523m in IPO
24th September 2021
Jordan Williams
Prosus, Visa, and Prudential Financial scored exits as Remitly went public, with Prudential divesting $32.5m of shares through the offering.
Freshworks' IPO tops $1bn
23rd September 2021
Jordan Williams
Alphabet-backed CRM software provider Freshworks floated above its range and now boasts a market cap of $13.5bn.
© 2021 Mawsonia Ltd. All rights reserved.
test reg

Login

Forgot password?

Not yet subscribed?

See your subscription offers here